高风险成人乙型肝炎疫苗接种的挑战:一项试点项目
美国CDC于2012至2015年资助14个卫生部门开展高风险成人乙型肝炎疫苗试点项目,评估疫苗利用、剂量系列完成情况及实施挑战。6个受资助者报告了患者层面的剂量完成数据,共接种47,911剂,首剂后40.4%接种第二剂,22.3%完成三剂系列;完成率在性病诊所最低(17.1%),在地方卫生部门诊所最高(60.6%)。
要点
- 高风险成人乙肝疫苗三剂系列完成率整体偏低,首剂后仅22.3%完成三剂。
- 性病诊所接种总剂量最多但三剂完成率最低(17.1%)。
- 地方卫生部门诊所三剂完成率最高(60.6%),联邦合格健康中心为38.0%。
核心结论
- 所有场所的乙肝疫苗剂量系列完成率均低,在患者可能不易返回随访的场所(如性病诊所)最低。
- 常规评估高风险成人的乙肝疫苗接种需求,包括在可用时使用免疫信息系统,可能促进剂量系列完成。
研究设计与样本
- CDC于2012至2015年资助14个卫生部门实施高风险成人乙肝疫苗试点项目。
- 受资助者与为HBV感染风险增加人群提供医疗服务的场所合作,汇总报告接种剂量、剂量系列完成情况及挑战至CDC。
主要发现
- 14个受资助者中6个报告了患者层面的剂量系列完成数据,共接种47,911剂。
- 接种第一剂者中,40.4%接种第二剂,22.3%接种第三剂。
- 地方卫生部门诊所三剂系列完成率为60.6%(531/876),联邦合格健康中心为38.0%(923/2432)。
- 性病诊所接种总剂量最多(17,173剂,占47,911剂的35.8%),但三剂系列完成率低(17.1%)。
临床怎么用
- 应常规评估高风险成人的乙肝疫苗接种需求。
- 在可用时利用免疫信息系统或其他追踪系统促进剂量系列完成。
- 针对患者可能不易返回随访的场所(如性病诊所)需加强随访和提醒策略。
局限性
- 仅6个受资助者能够报告患者层面的剂量系列完成数据,数据完整性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute hepatitis B virus (HBV) infections in the United States occur predominantly among persons aged 30-59 years. The Centers for Disease Control and Prevention (CDC) recommends vaccination of adults at increased risk for HBV infection. Completing the hepatitis B (HepB) vaccine dose-series is critical for optimal immune response. OBJECTIVES: CDC funded 14 health departments (awardees) from 2012 to 2015 to implement a pilot HepB vaccination program for high-risk adults. We evaluated the pilot program to assess vaccine utilization; vaccine dose-series completion, including by vaccination location type; and implementation challenges. METHODS: Awardees collaborated with sites providing health care to persons at increased risk for HBV infection. Awardees collected information on doses administered, vaccine dose-series completion, and challenges completing and tracking vaccinations, including use of immunization information systems (IIS). Data were reported by each awardee in aggregate to CDC. RESULTS: Six of 14 awardees administered 47,911 doses and were able to report patient-level dose-series completion. Among persons who received dose 1, 40.4% received dose 2, and 22.3% received dose 3. Local health department clinics had the highest 3-dose-series completion, 60.6% (531/876), followed by federally qualified health centers at 38.0% (923/2432). While sexually transmitted diseases (STD) clinics administered the most doses in total (17,173 [35.8% of 47,911 doses]), 3-dose-series completion was low (17.1%). The 14 awardees reported challenges regarding completing and tracking dose-series, including reaching high-risk adults for follow-up and inconsistencies in use of IIS or other tracking systems across sites. CONCLUSIONS: Dose-series completion was low in all settings, but lowest where patients may be less likely to return for follow-up (e.g., STD clinics). Routinely assessing HepB vaccination needs of high-risk adults, including through use of IIS where available, may facilitate HepB vaccine dose-series completion.
引用
- Bridges CB, Watson TL, Nelson NP, et al. Challenges with hepatitis B vaccination of high risk adults - A pilot program. Vaccine. 2019. PMID: 31303523. doi:10.1016/j.vaccine.2019.05.089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。